Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Patient managed at the IUCT-O and by a private speech therapist (near the patient's home)..
- Who it may be relevant to
- Registry conditions: ORL Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Interventional, prospective, single-centre study aimed to evaluate the impact of a video-assisted remote speech therapy consultation in relation to the complexity and specificity of the care of patients with ORL cancer. Three indications will be studied: phonation problems, swallowing problems and other problems. The study will be conducted on a population of patients with T3, T4 ORL cancer requiring speech therapy. Each patient included will have a video-assisted speech therapy consultation with a private speech therapist and an expert speech therapist. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire. At the follow-up visit following the video-assisted consultation, the patient will have completed participation in the study.
Interventions
- Other Patient managed at the IUCT-O and by a private speech therapist (near the patient's home).
Each patient included will have a video-assisted remote speech therapy consultation with a private speech therapist (near the patient's home) and the expert speech therapist of IUCT-O center. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire.
Primary outcome measures
- The rate of patients for whom tele-therapy will be considered successful. [Time frame: 12 months for each patient]
Secondary outcome measures (1)
- The rate of patients with full or partial resolution of speech-language pathology at the end of the telecare consultation. [Time frame: 12 months for each patient]
Eligibility criteria
Inclusion criteria
- Age ≥ 18 years at study entry.
- Patient with carcinological pathology of the VADS, relevant to surgery and/or radiotherapy and/or chemotherapy.
- Patient managed at the IUCT-O and by a private speech therapist (near the patient's home).
- Patient affiliated to a Social Security system in France.
- Patient having signed informed consent prior to inclusion in the study and prior to any specific study procedure.
Exclusion criteria
- Pregnant or lactating women.
- Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol.
- Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
France · 1 center
- Institut Universitaire du Cancer de Toulouse - Oncopole — Toulouse
Identifiers
NCT: NCT04940000 · 21VADS03